JP2023510289A5 - - Google Patents
Info
- Publication number
- JP2023510289A5 JP2023510289A5 JP2022542050A JP2022542050A JP2023510289A5 JP 2023510289 A5 JP2023510289 A5 JP 2023510289A5 JP 2022542050 A JP2022542050 A JP 2022542050A JP 2022542050 A JP2022542050 A JP 2022542050A JP 2023510289 A5 JP2023510289 A5 JP 2023510289A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic agent
- agent according
- immunogenic
- hydrophobic
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020900058 | 2020-01-09 | ||
| AU2020900058A AU2020900058A0 (en) | 2020-01-09 | Self-assembling, self-adjuvanting system for delivery of vaccines | |
| PCT/AU2021/050012 WO2021138721A1 (en) | 2020-01-09 | 2021-01-08 | Self-assembling, self-adjuvanting system for delivery of vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023510289A JP2023510289A (ja) | 2023-03-13 |
| JP2023510289A5 true JP2023510289A5 (enExample) | 2024-01-09 |
Family
ID=76787402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542050A Pending JP2023510289A (ja) | 2020-01-09 | 2021-01-08 | ワクチン送達のための自己組織化自己アジュバント系 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230090311A1 (enExample) |
| EP (1) | EP4087606A1 (enExample) |
| JP (1) | JP2023510289A (enExample) |
| AU (1) | AU2021205866A1 (enExample) |
| CA (1) | CA3163999A1 (enExample) |
| WO (1) | WO2021138721A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12021050442A1 (en) * | 2021-08-13 | 2023-06-05 | Univ Of The Philippines Through The Univ Of The Philippines Manila | ANTIPEPTIDE IMMUNOGLOBULINS TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) SPIKE GLYCOPROTEIN (S PROTEIN) EPITOPES AND COGNATE IMMUNOGENS, METHODS FOR PRODUCING AND UTILIZING THE SAME, AND ANTIGEN DETECTION SYSTEMS RELATING THERETO |
| US20240139312A1 (en) * | 2022-05-27 | 2024-05-02 | Design-Zyme LLC | Universal adjuvant for nasal, oral, and intramuscular delivery of vaccines |
| US20240156958A1 (en) * | 2022-11-02 | 2024-05-16 | Design-Zyme LLC | Self-adjuvanting multi-protein complexes for modular vaccine production |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107106668A (zh) * | 2014-12-10 | 2017-08-29 | 华西亚生医有限公司 | 用于免疫中的有效抗体生产的新颖蛋白质结构 |
| WO2018187515A1 (en) * | 2017-04-04 | 2018-10-11 | Avidea Technologies, Inc. | Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response |
| JP7194442B2 (ja) * | 2017-08-07 | 2022-12-22 | 国立大学法人東京農工大学 | 抗原組成物 |
| CN112566672A (zh) * | 2018-05-22 | 2021-03-26 | 阿维迪科技公司 | 制造基于肽的疫苗的改进方法 |
| CN111983226A (zh) * | 2020-03-25 | 2020-11-24 | 新加坡国立大学 | SARSr-CoV抗体的检测 |
| KR20250107297A (ko) * | 2020-04-02 | 2025-07-11 | 리제너론 파아마슈티컬스, 인크. | 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편 |
-
2021
- 2021-01-08 WO PCT/AU2021/050012 patent/WO2021138721A1/en not_active Ceased
- 2021-01-08 JP JP2022542050A patent/JP2023510289A/ja active Pending
- 2021-01-08 EP EP21738711.7A patent/EP4087606A1/en not_active Withdrawn
- 2021-01-08 CA CA3163999A patent/CA3163999A1/en active Pending
- 2021-01-08 AU AU2021205866A patent/AU2021205866A1/en not_active Abandoned
- 2021-01-08 US US17/791,856 patent/US20230090311A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023510289A5 (enExample) | ||
| JP5276598B2 (ja) | コイルドコイル構造を有するリポペプチドビルディングブロック、リポペプチドヘリックスバンドル、合成ウイルス様粒子、および医薬製剤 | |
| KR101617790B1 (ko) | 치료, 진단과 실험적 혼합물들의 운반을 위한 공학적으로 가변된 나노입자 및 치료용 관련 조성물 | |
| Spicer et al. | Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications | |
| WO2021115497A3 (zh) | 蛋白-药物偶联物和定点偶联方法 | |
| CN107708671B (zh) | 包含钴卟啉-磷脂缀合物和聚组氨酸标签的纳米结构 | |
| JP5751741B2 (ja) | 免疫原性組成物および使用法 | |
| WO1999007728A2 (fr) | Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives | |
| JP2010254700A (ja) | 膜転位剤および製薬学的有効成分の複合物 | |
| JP2009521908A5 (enExample) | ||
| JP2002514892A (ja) | 遺伝子治療における合成ウイルス様粒子の使用 | |
| WO2013065009A1 (en) | A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly | |
| EP1286700A2 (en) | Tumor activated prodrug compounds | |
| JPH06220070A (ja) | リン脂質誘導体及びそれを含有するリポソーム | |
| RU2005130173A (ru) | Использование лектинов для активации олигомеризации гликопротеидов и антигенных молекул | |
| JP2003517300A5 (enExample) | ||
| JP2023532290A5 (enExample) | ||
| CA2654073A1 (en) | Liposome-mediated native chemical ligation | |
| JP2006515744A5 (enExample) | ||
| Salmaso et al. | Nanotechnologies in protein delivery | |
| EP0306912A2 (en) | Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same. | |
| JP2022514348A5 (enExample) | ||
| EP1704167B1 (en) | A method to make a peptide-carrier conjugate with a high immunogenicity | |
| CN100387616C (zh) | 获得可增强特异交叉反应性的抗原结构的方法 | |
| RU2007106900A (ru) | Иммуногенные комплексы, способ их приготовления и их применение в фармацевтических композициях |